An analytic theory for the resolution attainable using eclipse mapping of exoplanets

We present an analytic theory for the resolution attainable via eclipse mapping of exoplanets, based on the Fourier components of the brightness distribution on the planetary disk. We find that the impact parameter determines which features can and cannot be seen, via the angle of the stellar edge relative to the axis of the orbit during the eclipse. We estimate the signal-to-noise ratio as a function of mapping resolution, and use this to determine the attainable resolution for a given star-planet system. We test this theory against numerical simulations and find good agreement; in particular, our predictions for the resolution as a function of stellar edge angle are accurate to the simulated data to within 10% over a wide range of angles. Our prediction for the number of spatial modes that can be constrained given a light curve error is similarly accurate. Finally, we give a list of exoplanets with the best expected resolution for observations with the NIRISS SOSS, NIRSpec G395H, and MIRI LRS instruments on JWST.Comment: 11 pages, 9 figures. Submitted to MNRA

An analytical theory for the resolution attainable using eclipse mapping of exoplanets

We present an analytical theory for the resolution attainable via eclipse mapping of exoplanets, based on the Fourier components of the brightness distribution on the planetary disc. We find that the impact parameter determines which features can and cannot be seen, via the angle of the stellar edge relative to the axis of the orbit during the eclipse. We estimate the signal-to-noise ratio as a function of mapping resolution, and use this to determine the attainable resolution for a given star–planet system. We test this theory against numerical simulations and find good agreement; in particular, our predictions for the resolution as a function of stellar edge angle are accurate to the simulated data to within 10 per cent over a wide range of angles. Our prediction for the number of spatial modes that can be constrained given a light-curve error is similarly accurate. Finally, we give a list of exoplanets with the best expected resolution for observations with the NIRISS SOSS, NIRSpec G395H, and MIRI LRS instruments on JWST

An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus enters host cells via an interaction between its Spike protein and the host cell receptor angiotensin-converting enzyme 2 (ACE2). By screening a yeast surface-displayed library of synthetic nanobody sequences, we developed nanobodies that disrupt the interaction between Spike and ACE2. Cryo-electron microscopy (cryo-EM) revealed that one nanobody, Nb6, binds Spike in a fully inactive conformation with its receptor binding domains locked into their inaccessible down state, incapable of binding ACE2. Affinity maturation and structure-guided design of multivalency yielded a trivalent nanobody, mNb6-tri, with femtomolar affinity for Spike and picomolar neutralization of SARS-CoV-2 infection. mNb6-tri retains function after aerosolization, lyophilization, and heat treatment, which enables aerosol-mediated delivery of this potent neutralizer directly to the airway epithelia

An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus enters host cells via an interaction between its Spike protein and the host cell receptor angiotensin-converting enzyme 2 (ACE2). By screening a yeast surface-displayed library of synthetic nanobody sequences, we developed nanobodies that disrupt the interaction between Spike and ACE2. Cryo-electron microscopy (cryo-EM) revealed that one nanobody, Nb6, binds Spike in a fully inactive conformation with its receptor binding domains locked into their inaccessible down state, incapable of binding ACE2. Affinity maturation and structure-guided design of multivalency yielded a trivalent nanobody, mNb6-tri, with femtomolar affinity for Spike and picomolar neutralization of SARS-CoV-2 infection. mNb6-tri retains function after aerosolization, lyophilization, and heat treatment, which enables aerosol-mediated delivery of this potent neutralizer directly to the airway epithelia